Sally C. Pipes
Blog
Don’t Take Cutting-Edge Drugs for Granted
It’s hard to imagine a more destructive plan. Importing foreign price controls on prescription drugs would reduce access to existing treatments for everything from rare diseases to cancer. To understand why, consider two recent pieces by Michael Baker for the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems.” ...
Commentary
Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans
Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term. Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.” The idea is to bring other developed countries’ lower drug prices to the United ...
Commentary
Colorado Gov. Polis’ new ‘study’ is a waste of time
The drive for single-payer health care won’t die. Gov. Jared Polis just signed legislation to spend $400,000 on a new “study” of how to bring government-run health care to the state. It’s a colossal waste of time and money. Decades of evidence from Canada and the United Kingdom show that ...
Commentary
Why sunblock in the U.S. is so much worse than in the E.U.
One in five Americans will develop skin cancer by age 70. Yet regulators in the United States have not approved sunscreens that can more effectively prevent the disease. Such safetyism makes little sense. Americans receive more diagnoses for skin cancer than for all other forms of cancer combined. It’s long ...
Blog
Read about the push for drug price controls
Trump and Biden Agree on Drug Pricing
Patients will pay dearly, as Michael Baker and Douglas Holtz-Eakin explain in two recent pieces for the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems. Biden signed the Inflation Reduction Act into law in 2022. It directs the feds to “negotiate” prices for a steadily increasing number of ...
Commentary
Republicans are right to reform Medicaid
House Republicans held the mark-up last week for their reconciliation package, which includes several significant reforms to Medicaid, the federal-state entitlement that provides health benefits to roughly one in five Americans. The package is not perfect. But it would restore some measure of fiscal sanity to the program by, among ...
Commentary
President Trump Hasn’t Given Up on Hospital Price Transparency
For markets to function efficiently, consumers need to know how much things cost. This is as true for eggs and milk as it is for medical care. And it was this very insight that motivated the rule that President Donald J. Trump implemented during his first term in 2019 ordering ...
Commentary
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs. The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without ...
Commentary
Is Era of Biomedical Innovation Wins Against Cancer Over?
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central ...
Commentary
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up. Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing ...
Don’t Take Cutting-Edge Drugs for Granted
It’s hard to imagine a more destructive plan. Importing foreign price controls on prescription drugs would reduce access to existing treatments for everything from rare diseases to cancer. To understand why, consider two recent pieces by Michael Baker for the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems.” ...
Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans
Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term. Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.” The idea is to bring other developed countries’ lower drug prices to the United ...
Colorado Gov. Polis’ new ‘study’ is a waste of time
The drive for single-payer health care won’t die. Gov. Jared Polis just signed legislation to spend $400,000 on a new “study” of how to bring government-run health care to the state. It’s a colossal waste of time and money. Decades of evidence from Canada and the United Kingdom show that ...
Why sunblock in the U.S. is so much worse than in the E.U.
One in five Americans will develop skin cancer by age 70. Yet regulators in the United States have not approved sunscreens that can more effectively prevent the disease. Such safetyism makes little sense. Americans receive more diagnoses for skin cancer than for all other forms of cancer combined. It’s long ...
Read about the push for drug price controls
Trump and Biden Agree on Drug Pricing
Patients will pay dearly, as Michael Baker and Douglas Holtz-Eakin explain in two recent pieces for the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems. Biden signed the Inflation Reduction Act into law in 2022. It directs the feds to “negotiate” prices for a steadily increasing number of ...
Republicans are right to reform Medicaid
House Republicans held the mark-up last week for their reconciliation package, which includes several significant reforms to Medicaid, the federal-state entitlement that provides health benefits to roughly one in five Americans. The package is not perfect. But it would restore some measure of fiscal sanity to the program by, among ...
President Trump Hasn’t Given Up on Hospital Price Transparency
For markets to function efficiently, consumers need to know how much things cost. This is as true for eggs and milk as it is for medical care. And it was this very insight that motivated the rule that President Donald J. Trump implemented during his first term in 2019 ordering ...
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs. The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without ...
Is Era of Biomedical Innovation Wins Against Cancer Over?
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central ...
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up. Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing ...
